Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments.
Quantitative receptor autoradiography was used to study the effects of the selective serotonin reuptake inhibitors citalopram and fluoxetine and the tricyclic antidepressant imipramine on the regulation of beta 1-adrenergic receptors in the rat brain. Rats were treated with saline, citalopram (10 mg kg-1), fluoxetine (10 mg kg-1), or imipramine (15 mg kg-1) SC once daily for 14 days. [125I]Iodocyanopindolol binding to beta 1-adrenergic receptors was found to increase significantly in the caudate-putamen and the somatosensory areas of the frontal cortex after both citalopram and fluoxetine treatments. Imipramine treatment elicited a marked decrease in beta 1 binding in the outer laminae of the cingulate cortex, as well as in the motor and somatosensory areas of the frontal cortex. In a separate experiment, rats were treated with saline, citalopram (2.5, 10 and 20 mg kg-1) or fluoxetine (2.5, 10 and 20 mg kg-1) SC once daily for 14 days. The effects of citalopram and fluoxetine on beta 1 receptors in the somatosensory cortex and caudate-putamen were replicated. These results demonstrate that chronic administration of selective serotonin reuptake inhibitors, in contrast to imipramine, can cause a regional up-regulation of beta 1-adrenergic receptors in the rat brain.
Pälvimäki
E P
EP
Department of Pharmacology, University of Turku, Finland.
Laakso
A
A
Kuoppamäki
M
M
Syvälahti
E
E
Hietala
J
J
D058665:Adrenergic beta-1 Receptor Agonists; D000818:Animals; D001345:Autoradiography; D001923:Brain Chemistry / Q000187:drug effects; D015283:Citalopram / Q000494:pharmacology*; D005473:Fluoxetine / Q000494:pharmacology*; D007091:Image Processing, Computer-Assisted; D007099:Imipramine / Q000494:pharmacology; D020120:Iodocyanopindolol; D008297:Male; D010869:Pindolol / Q000031:analogs & derivatives; D051381:Rats; D017207:Rats, Sprague-Dawley; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology*; D015854:Up-Regulation / Q000187:drug effects*
D058665:Adrenergic beta-1 Receptor Agonists; D015283:Citalopram; D005473:Fluoxetine; D007099:Imipramine; D020120:Iodocyanopindolol; D010869:Pindolol; D017367:Selective Serotonin Reuptake Inhibitors